November 24, 2008 – 5:52 pm
Allos Therapeutics, Inc announced today that the FDA granted Orphan Drug Designation to pralatrexate (PDX) for the treatment of patients with Diffuse Large B-Cell Lymphoma. This marks the second Orphan Drug Designation for PDX – the original designation covers the treatment of patients with T-cell lymphoma.
November 24, 2008 – 3:30 pm
MicroPhage, Inc. announced it closed its most recent round of financing last week. This round brings the company’s total capital raised to $12M and included both new and existing investors (RockyRadar is trying to track down more specifics on the most recent round). Regardless of the exact details, closing financing in the current [...]
November 21, 2008 – 7:19 pm
Today, the Colorado BioScience Association (CBSA) announced its new Executive Director, John Collar. Collar has broad experience across the biosciences with a recent focus in the laboratory and testing field. Currently, Collar serves as COO of Matrilinex (Westminster), a DNA testing lab startup. His resume includes leadership roles at a mix of [...]
November 17, 2008 – 1:45 pm
Entrepreneurs embarking into the wilderness of commercial uncertainty expect to face certain challenges, from funding difficulties to retaining key employees. But few prepare for that moment when they stumble upon industrial espionage in progress. “I was at a Veterans Administration conference in California with my original prototypes,” remembers Jerome Rifkin, CEO of Tensegrity Prosthetics. “I [...]
November 14, 2008 – 7:52 pm
BioWest Day 2 offered two presentations and a job fair to round out an exciting two days. The day began with a panel discussion of what large pharma and medical device companies are looking for. Panelists Dick Brandl and David Snitman covered the topic from opposite ends of the spectrum. Brandl serves [...]
November 14, 2008 – 1:27 am
The first day of CBSA’s BioWest 2008 Conference offered participants timely and far reaching perspectives on the future of biosciences , from the impact of election results and sliding stocks to the art of innovation.
The day kicked off with an informative and highly relevant — if not particularly rosy — picture of the future of [...]
November 14, 2008 – 12:28 am
Oberon FMC won the 2008 BioWest Venture Showcase, including the $10,000 prize sponsored by Dorsey and White. Oberon FMC, which seeks to provide a cost-effective protein meal for use in fish feed, is a Colorado based company headquartered in Idaho Springs. Despite facing an audience who may be more comfortable contemplating the latest [...]
November 5, 2008 – 2:48 pm
Replidyne, Inc of Louisville, CO and Cardiovascular Systems, Inc. (CSI) of St. Paul, MN announced Tuesday that they have entered into a definitive merger agreement. Under the transaction which has been approved by both company’s boards of directors but still needs shareholder approval, Replidyne would issue new shares of common stock to CSI shareholders. [...]
November 3, 2008 – 9:57 pm
Yesterday, GlobeImmune, Inc announced four-week results from its Phase 2 clinical trial of GI-5005. The 140 patient randomized, multi-center trial compared standard of care (SOC), pegylated interferon and ribavirin, to SOC plus GI-5005 in patients with chronic genotype 1 hepatitis C infection. Patients in the GI-5005 treatment arm showed an overall rate of [...]
November 3, 2008 – 1:55 pm
In 1880 Thomas Edison patented the electrical fuse in order to intentionally create a weak link in the wiring of his newly invented artificial light strings. Edison believed that in the event of electrical overload it was best to isolate the location of stress for both safety and convenience, so when the system became disrupted [...]
